product summary
Loading...
company name :
Sino Biological
product type :
antibody
product name :
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit PAb, Antigen Affinity Purified
catalog :
40589-T62
quantity :
100 µL
price :
299 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
application :
western blot, ELISA
more info or order :
Sino Biological product webpage
citations: 9
Reference
Lu J, Tan S, Gu H, Liu K, Huang W, Yu Z, et al. Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies. Emerg Microbes Infect. 2024;13:2321994 pubmed publisher
Sun Y, Tian Y, Wu S, Huang A, Hu Y, Liao Z, et al. Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity. Cell Rep Med. 2023;4:101303 pubmed publisher
Tan S, Zhao J, Hu X, Li Y, Wu Z, Lu G, et al. Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants. Sci Bull (Beijing). 2023;68:3192-3206 pubmed publisher
Yu D, Han H, Yu J, Kim J, Lee G, Yang J, et al. Pseudoknot-targeting Cas13b combats SARS-CoV-2 infection by suppressing viral replication. Mol Ther. 2023;31:1675-1687 pubmed publisher
Rossotti M, van Faassen H, Tran A, Sheff J, Sandhu J, Duque D, et al. Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models. Commun Biol. 2022;5:933 pubmed publisher
Petersen J, Lu J, Fitzgerald W, Zhou F, Blank P, Matthies D, et al. The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles. bioRxiv. 2022;: pubmed publisher
Ren W, Ju X, Gong M, Lan J, Yu Y, Long Q, et al. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. MBio. 2022;13:e0009922 pubmed publisher
Bao L, Zhang C, Lyu J, Yi P, Shen X, Tang B, et al. Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker. J Appl Microbiol. 2022;132:2421-2430 pubmed publisher
Zhu S, Liu Y, Zhou Z, Zhang Z, Xiao X, Liu Z, et al. Genome-wide CRISPR activation screen identifies candidate receptors for SARS-CoV-2 entry. Sci China Life Sci. 2021;: pubmed publisher
product information
Catalog Number :
40589-T62
Product Name :
SARS-CoV-2 (2019-nCoV) Spike Antibody, Rabbit PAb, Antigen Affinity Purified
Product Type :
Antibody
Host Species :
Rabbit
Clonality :
polyclonal
Conjugation :
Unconjugated
Isotype :
IgG
Size :
100 µL
List Price :
299 USD
Product Description :
Produced in rabbits immunized with purified, recombinant SARS-CoV-2 / 2019-nCoV Spike Protein (S1+S2 ECD)(Catalog#40589-V08B1; YP_009724390.1; Val16-Pro1213). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Spike affinity chromatography.
SpeciesSummary :
SARS-CoV-2
ALTnames :
Spike
Immunogen :
Recombinant SARS-CoV-2 / 2019-nCoV Spike Protein (Catalog#40589-V08B1)
Purity :
Protein A & Antigen Affinity
Buffer :
0.2 μm filtered solution in PBS
Application Summary :
WB,ELISA
Storage :
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
more info or order :
Sino Biological product webpage
company information
Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com
86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.